*In alphabetical order

Dr. Petros Aristodemou, FRCOphth, Consultant Vitreoretinal Surgeon. He is a consultant ophthalmic surgeon with a specialist interest in retinal and macular disease. He trained at Royal London Hospital, St Thomas’ Hospital and Bristol Eye Hospital. He also has an active research interest in big data analysis for clinical outcomes of cataract surgery and the refinement of intraocular lens power calculations. 




Dr. Andreas Charalambous started his nursing career in 1995. He obtained his BSc in Nursing Science in 1999 by the Northumbria University (U.K), his MSc (Nursing Science) from the Middlesex University (UK) in 2002 and his PhD (Oncology Nursing) from the same University in 2008. With a clinical background in cancer care and more specifically in oncology, he has worked clinically and academically in Cyprus and the U.K. He has a long and proven track in academia since 2004. Presently he is an Associate Professor of Oncology and Palliative Care at the Cyprus University of Technology and a Docent at University of Turku (Finland). He is the founder and current President of the Cyprus Oncology Nursing Society and EONS President-Elect. He is involved in National and International research programs in various fields of cancer care. He has published over 100 National and International publications in esteem journals in the fields of cancer care, symptom management, informal caregivers, quality care and supportive care.


Mr. Loukas Christodoulou, is a Clinical Psychologist of PASYKAF (Cyprus Association of Cancer Patients and Friends) since 2016. He obtained his BSc in Psychology in 2011, by the European University of Cyprus and his MSc in Clinical Psychology by the University of Nicosia in 2016. He has a particular interest in psychological support of cancer patients and so he is expected to begin a doctoral degree in this field soon. He is a member of Cyprus Psychological Association since 2011, and he participated in many conferences, seminars and researches.


Dr. Ourania Deimetriadou is the Director in the Department of Nuclear Medicine at the Limassol General Hospital. She graduated from the medical faculty of Charles University in Prague and specialized in Radiology and Nuclear Medicine. She has several publications in medical journals and presentations at conferences both in Cyprus and abroad. She took part in research projects, in collaboration with universities both in Cyprus and abroad, funded by the research promotion Foundation and European funds. She is the President of the Cyprus society of nuclear medicine and Treasurer of the Radiological Society of Cyprus and member of the European Association of Nuclear medicine, British Nuclear Medicine Society and American Society of Nuclear Cardiology.
She was trained in clinicalauditby the International Atomic Energy Agency and pioneered in the accreditation of the departments in public health hospitals by achieving accreditation of  Nuclear Medicine Department of Limassol General Hospital in 2010. She has gotten the degree of Higherin accounting showing practically her readiness for the autonomy of Public Hospitals. From January 2019 she will operate the DemAndScan Nuclear Diagnostic Center in Paphos.


Mrs. Anna Demetriou holds a BSc degree in Statistics and a Master’s Degree in Business Administration (MBA). Since 2007 she works as a Statistical Officer at the Health Monitoring Unit of the Ministry of Health, focusing in data analysis for cancer data. 
Her participation in several post-graduate courses regarding Cancer Data management and analysis, quality assurance, survival analysis and epidemiology, allowed her to take part in numerous research projects and publications for Cancer Registry Data.
She is also working in analyzing, HIV/AIDS registry data and other smaller surveys such as the Point Prevalence Survey of Hospital Acquired Infections and Antibiotics Use, and Immunization Coverage Surveys.
She is a Member of the Expert Group on Health Information (EGHI) and Expert Group on Health Systems Performance Assessment (HSPA) of the European Commission.


Dr. Konstantinos Ferentinos was born in Ioannina Greece, where he studied Medicine. He was awarded the degree in Medicine in 2007. He was resident in the Department of Radiation Oncology at Klinikum Offenbach in Germany under the supervision of the renowned oncologist Prof. Zamboglou. His main area of interest are Interventional Radiotherapy and novel radiation techniques.  In 2012 he obtained the PhD in Medicine at the Goethe University Frankfurt. From 2013 to 2015 he worked as consultant at Klinikum Offenbach, where he was responsible for the department of Stereotactic Radiotherapy. In 2016 he worked as senior consultant in the Department of Interventional Radiotherapy at the Iatriko Kentro in Athens. Since 2017 he is the head of the Department of Radiation Oncology at the German Oncology Center in Limassol.


Dr. Konstantina Frangia-Tsivou, is the Head Pathologist and CEO of HistoBio Diagnosis S.A. for Pathology Services in Athens , Greece [2010- ]. She received her M.D., Ph.D. and Specialty in Anatomic and Clinical Pathology Degrees, from Medical School, University of Athens.
Elected President of the Hellenic Society for Study of Melanoma [ΕΛΕΜΜΕΛ]  and of the MELAMPOUS Organization against Melanoma in Greece. Elected member and representative of Greece in the W.H.O Melanoma Programme member of the W.H.O. Rare Tumor Group and Co-Chairman of the MMOF’s Mediterranean Melanoma Group.
Research Fellow in Anticancer Research Program, Alexandra Hospital, Athens, Greece. Research Fellow in Dermatopathology and in Melanoma Research, MGH, Boston, USA. Head Pathologist of Pathology Department in SOTIRIA General Hospital of Athens [2003-2009], Professor of Anatomy and Pathology in the Hellenic Military School of Nurse Officers [1991-2003] , Visiting Lecturer in Dermatopathology [MGH, Harvard Medical School, Boston, USA-1999].
Co-author in articles and books related to melanoma, lung cancer and telepathology. Major clinical, research and scientific interests: skin and eye melanoma, lung cancer, immunity of solid tumours and prevention of melanoma. She is the main consultant pathologist for pigmented lesions in Greece and during the last 20 years has been co-ordinator of Programs against Melanoma in Greece.


Mr. Wouter Frank Hoelen is doing his PhD in Lymphology and Oncology and is mainly focused on pain in both fields. He is director of the Berekuyl multidisciplinary clinic and the Berekuyl academy where you can follow a study for Oncology Physical therapy in collaboration with the Vrije Universiteit Brussel. Recently he gave a course in Nicosia regarding Head & Neck cancer. He trained in 2004 all Pasykaf therapists in oedema therapy and comes back on a regular bases for an update. He is very interested in the multidisciplinary approach in Cancer REHAB and the link to Artificial Intelligence and E-health solutions.


Dr. Zoe Kordatou completed her studies in Medicine, at the Aristotelian University of Thessaloniki, Greece in 2004. Then she trained in Internal medicine  at Hippokrateion General Hospital in Thessaloniki, Greece (2007-2011). She completed her medical oncology Specialty Training at the Bank of Cyprus Oncology Center  in 2014. She worked in several hospitals in Ireland as a medical Oncology Fellow and at the Christie NHS Foundation Trust, UK  as an Oncology Clinical research Fellow (2015-2018). She is currently working as a medical Oncology Consultant at the Bank of Cyprus Oncology Center, with a site specialization in Skin cancer, Lung cancer and Germ cell tumors. (2018-today). She is also a member of ESMO and ASCO.


Dr. Georgia Koulermou is a plastic surgeon and is active in the private sector and at the American breast center. She is a certified Aesthetic and reconstructive surgeon, with a particular interest in breast surgery, skin cancer and melanoma.
She has graduated from the Medical School of University of Athens, from where she performed her surgical training specializing in plastic surgery. In addition, she was awarded her doctorate in medicine from University of Athens, with the title of “ Epidemiological study of skin melanoma in Greece”. In 1993, with her specialization in plastic surgery, she returned to Cyprus, and worked at the Plastic Surgery Department of “Archbishop Makarios” Hospital, Nicosia. From 1996 and onwards she became the director of the Plastic Surgery Clinic and Burns Unit of Nicosia General Hospital, a position that she undertook until November of 2017. Since then she is active as a Plastic Surgeon at the private sector.
She is an honorary Plastic Surgery Professor at the Medical School of University of Nicosia. In addition, she was a clinical collaborator at the Medical School of university of Cyprus, from its establishment until 2017. Furthermore, she is a visiting Plastic Surgery Professor at the postgraduate program of Frederick University. 
She has more that 300 published articles at international medical magazines and lectures as an invited speaker at conferences. She has presented a vast number of clinical and research work that pertains to burning disease and breast reconstruction after mastectomy and skin melanoma. She has consistently been awarded for her scientific work from the Greek Surgical Association, Memorial Hospital and the Greek Association of Wound Healing. Moreover, she has a specialization in breast surgery,  aesthetic and reconstruction after mastectomy, with continual specializations and scholarships abroad.
Finally, she is the writer of the book with title “ Clinical differential diagnosis of cutaneous melanoma”, published by εν τύποις 2017.


Dr. Paul Nathan is consultant medical oncologist at Mount Vernon Cancer Centre, Northwood, UK. His specialist interests are the treatment of malignant melanoma and renal cell carcinoma. His clinical training was through Cambridge and London having had an earlier scientific career in academia and the pharmaceutical industry.
He was the UK chief investigator on the COMBI-AD clinical trial. He is EORTC Uveal Melanoma lead, International Rare Cancer Initiative (IRCI) UK Uveal melanoma lead and chaired the UK guideline group on Uveal Melanoma. He chairs the NCRI Bladder and Renal Carcinoma Clinical Studies Group.
He is UK chief investigator and steering committee member for a number of academic and pharma sponsored melanoma and renal carcinoma studies. He has authored many papers and book chapters. He is an advisory board member for a number of pharmaceutical companies. He is a trustee of Melanoma Focus the UK national melanoma charity.


Mr. Andreas Papageorgiou is the current manager of “Afetiria”, PASYKAF’s Rehabilitation Centre for Cancer Survivors based in Limassol, Cyprus. He has a particular interest in the areas of rehabilitation, patient support after cancer treatment and survivorship. After his bachelor degree in Social Work, he went on to study for a Social Policy Masters degree at the University of Birmingham, from which he graduated in 2009. In 2010 he further his studies by acquiring a diploma in Academic Social Work Supervision by the University of Nicosia and since 2019, he has been undertaking the MBA program at the University of Cyprus, expected to graduate in 2020. Among other things, Andreas is the President of the ‘Limassol Voluntary Association’ and an active member of the ‘Patients Support Working Group’ which is a part of the ‘European Cancer Leagues’.


Dr. Barbara Perić has been researching and working at the Institute of Oncology Ljubljana since 2003. Her most important work is surgery on skin melanoma and other skin cancers, thyroid surgery, minimally invasive parathyroid surgery, and breast cancer surgery. Her work includes skin examination with the help of dermoscopy, consulting on familial disease and the treatment of benign breast conditions. She is involved in international clinical research with researchers and doctors from Australia, the USA and the UK.  Barbara is the author and co-author of articles in Slovenian and foreign peer-reviewed journals. At work, she is often joined by Slovenian and foreign medical students.
She received her PhD in 2009. In her dissertation, she analyzed survival of cutaneous melanoma in relation to stage and found mutations of certain genes in individuals with familial melanoma in Slovenia. Barbara completed her specialization in general surgery with distinction in 2013. She continues her professional development, and in 2014 she took the European Board of Surgery Qualification (EBSQ) – Surgical Oncology. 


Mr. Mandeep Sagoo is Professor of Ophthalmology and Ocular Oncology at UCL Institute of Ophthalmology and Consultant Ophthalmic Surgeon with subspecialist interest in adult and paediatric eye tumours at the London Ocular Oncology Service at Moorfields Eye Hospital and St. Bartholomew’s Hospital and the London Retinoblastoma Service at Royal London Hospital.
Having graduated from Cambridge University, he undertook residency in Ophthalmology at Oxford and then Moorfields Eye Hospital. His Fellowship training was in Ocular Oncology, as a Fulbright Scholar, under Dr Jerry Shields and Dr Carol Shields at Wills Eye Hospital and Medical Retina Fellowship at Moorfields. He holds over 20 academic awards and prizes, including the Gedge Prize of Cambridge University, John Glyn Young Fellows Prize of Royal Society of Medicine, PJ Hay Medal of the North of England Ophthalmology Society, the Syme Medal and the King James IV Professorship of Royal College of Surgeons of Edinburgh. He has written 5 book chapters and over 100 academic papers. He is a Member of Macula Society, Council Member of Oxford Ophthalmological Congress and has served as Honorary Secretary of the International Society of Ocular Oncology. He has recently been Visiting Professor of Ophthalmology at Stanford University, USA.


Ms. Agathi Skoutari obtained her Bsc in Computer Science in 2009 , at the European University of Cyprus.  Since 2007 she has been working for Epic Cyprus as a Business Sales Coordinator.  In 2010 she was diagnosed with cutaneous melanoma Stage 2b.  Since 2017 she is a member of the board of PASYKAF and also a member of the PASYKAF Melanoma Team. In 2017 she became a member of MPNE (Melanoma Patient Network Europe) and she represents the Cyprus Melanoma Patients to the MPNE conferences.


Dr. Robert Watson studied medicine at the University of Oxford, where he graduated with a First Class and Distinction, before undertaking the Academic Foundation Programme in London. Following this, he worked for the Nuffield Trust think tank before returning to Oxford to complete an Academic Clinical Fellowship in Medical Oncology. Here he worked in the Fairfax Group at the Weatherall Institute of Molecular Medicine, University of Oxford, and successfully competed for a Cancer Research UK grant to fund his work. Following the commencement of specialist training in Medical Oncology, he is now completing a PhD in the Fairfax Group, funded by a Wellcome Trust Fellowship. Alongside his academic and clinical work, Robert is a Lecturer in Medicine and Director of Graduate Entry Medicine at Worcester College, University of Oxford.